Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ray Kim

Showing results (181-190 of 269) with videos related to

Pageof 27
Sort By:
Hepatology (Baltimore, Md.)|January 28, 2006
Deaths on the liver transplant waiting list: an analysis of competing risksW Ray Kim, Terry M Therneau, Joanne T Benson, et al.
Hepatology (Baltimore, Md.)|March 5, 2004
MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patientsWalter K Kremers, Marrije van IJperen, W Ray Kim, et al.
Hepatology (Baltimore, Md.)|September 18, 2025
Erratum: Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 Practice Guidance by the American Association for the Study of Liver DiseasesScott W Biggins, Paulo Angeli, Guadalupe Garcia-Tsao, et al.
Hepatology Communications|May 16, 2018
A real-world observational cohort of patients with primary biliary cholangitis: TARGET-primary biliary cholangitis study design and rationaleCynthia Levy, Christopher L Bowlus, Elizabeth Carey, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 21, 2013
Impact of the center on graft failure after liver transplantationSumeet K Asrani, W Ray Kim, Erick B Edwards, et al.
Mayo Clinic Proceedings|September 3, 2010
Endothelial nitric oxide synthase gene variation associated with chronic kidney disease after liver transplantKiran Bambha, W Ray Kim, Charles B Rosen, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 1, 2007
Can the model for end-stage liver disease be used to predict the prognosis in patients with Budd-Chiari syndrome?Sarwa Darwish Murad, W Ray Kim, Piet C de Groen, et al.
Hepatology (Baltimore, Md.)|May 7, 2014
Continuation of metformin use after a diagnosis of cirrhosis significantly improves survival of patients with diabetesXiaodan Zhang, William S Harmsen, Teresa A Mettler, et al.
Transplantation|January 9, 2018
Liver Simulated Allocation Modeling: Were the Predictions Accurate for Share 35?Aparna Goel, W Ray Kim, Joshua Pyke, et al.
Alimentary Pharmacology & Therapeutics|February 9, 2022
Risk of hepatocellular carcinoma in treatment-naïve chronic hepatitis B patients receiving tenofovir disoproxil fumarate versus entecavir in the United StatesW Ray Kim, Laura E Telep, Belinda Jump, et al.
Pageof 27

Showing results (181-190 of 269) with videos related to

Sort By:
Pageof 27
Hepatology (Baltimore, Md.)|January 28, 2006
Deaths on the liver transplant waiting list: an analysis of competing risksW Ray Kim, Terry M Therneau, Joanne T Benson, et al.
Hepatology (Baltimore, Md.)|March 5, 2004
MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patientsWalter K Kremers, Marrije van IJperen, W Ray Kim, et al.
Hepatology (Baltimore, Md.)|September 18, 2025
Erratum: Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 Practice Guidance by the American Association for the Study of Liver DiseasesScott W Biggins, Paulo Angeli, Guadalupe Garcia-Tsao, et al.
Hepatology Communications|May 16, 2018
A real-world observational cohort of patients with primary biliary cholangitis: TARGET-primary biliary cholangitis study design and rationaleCynthia Levy, Christopher L Bowlus, Elizabeth Carey, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 21, 2013
Impact of the center on graft failure after liver transplantationSumeet K Asrani, W Ray Kim, Erick B Edwards, et al.
Mayo Clinic Proceedings|September 3, 2010
Endothelial nitric oxide synthase gene variation associated with chronic kidney disease after liver transplantKiran Bambha, W Ray Kim, Charles B Rosen, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 1, 2007
Can the model for end-stage liver disease be used to predict the prognosis in patients with Budd-Chiari syndrome?Sarwa Darwish Murad, W Ray Kim, Piet C de Groen, et al.
Hepatology (Baltimore, Md.)|May 7, 2014
Continuation of metformin use after a diagnosis of cirrhosis significantly improves survival of patients with diabetesXiaodan Zhang, William S Harmsen, Teresa A Mettler, et al.
Transplantation|January 9, 2018
Liver Simulated Allocation Modeling: Were the Predictions Accurate for Share 35?Aparna Goel, W Ray Kim, Joshua Pyke, et al.
Alimentary Pharmacology & Therapeutics|February 9, 2022
Risk of hepatocellular carcinoma in treatment-naïve chronic hepatitis B patients receiving tenofovir disoproxil fumarate versus entecavir in the United StatesW Ray Kim, Laura E Telep, Belinda Jump, et al.
Pageof 27